Alimera Sciences: Q2 Earnings Snapshot
By AP News
Published - Aug 06, 2024, 10:58 AM ET
Last Updated - Aug 06, 2024, 10:58 AM EDT
ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Tuesday reported a loss of $3.3 million in its second quarter.
On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 6 cents.
The eye drug developer posted revenue of $27 million in the period.
Alimera Sciences shares have risen 28% since the beginning of the year. The stock has increased 68% in the last 12 months.
